Please wait
Healthcare · Diagnostics & Research · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$43.7B
N/A
39.06
Current price
$556.69
+0.3% todayUpdated just now
Open
$547.81
Previous close
$554.99
Day range
$543.60 – $561.24
Volume
N/A
39.1x P/E
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for IDXX, with its range and direction at a glance.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Investors usually follow IDXX for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 75/100 while there is no strong bear warning from the current data. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$338M
TTM (2026-06-30)
ROE
74.2%
Return on equity
ROA
27.1%
Return on assets
Debt / equity
0.68
Lower is usually safer.
P/B ratio
27.15
Useful for book value support.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Valuation still leaves room versus fair value and analyst anchors.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
$626.96
Analyst view
Buy
Analyst target
$698.92
Forecast refresh
Updated 12h ago
Quality score
73
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Sideways
-0.4% across the latest saved price window.
Volatility
High
Beta is 1.54. Price may swing more than the wider market.
52-week position
15% of range
Price is trading close to its 52-week low.
Volume confirmation
N/A
Comparable volume data is not available.
IDXX may also move because the HEALTHCARE sector may move with high_energy_costs. Confidence 63%.
PMG-MAN stated the pharmaceutical sector spends a large share of revenue on energy, reducing competitiveness industry-wide.
policy_stability_and_support
IDXX may also move because the HEALTHCARE sector may benefit from policy_stability_and_support. Confidence 60%.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
IDXX
IDEXX Laboratories, Inc.
Price: $556.69
P/E: 39.056297
Yield: N/A
ABBV
AbbVie Inc.
Price: $256.42
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.36
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $159.79
P/E: 27.310226
Yield: 0.0%
Industry
Diagnostics & Research
Employees
11000
Exchange
NMS
Ticker
IDXX
